ES336642A1 - Un metodo de preparacion de una composicion farmaceutica efectiva para aumentar el ritmo de aprendizaje y el grado deretencion memoristica en animales. - Google Patents

Un metodo de preparacion de una composicion farmaceutica efectiva para aumentar el ritmo de aprendizaje y el grado deretencion memoristica en animales.

Info

Publication number
ES336642A1
ES336642A1 ES336642A ES336642A ES336642A1 ES 336642 A1 ES336642 A1 ES 336642A1 ES 336642 A ES336642 A ES 336642A ES 336642 A ES336642 A ES 336642A ES 336642 A1 ES336642 A1 ES 336642A1
Authority
ES
Spain
Prior art keywords
compositions
oxazolidinone
imino
phenyl
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES336642A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES336642A1 publication Critical patent/ES336642A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
ES336642A 1966-02-10 1967-02-09 Un metodo de preparacion de una composicion farmaceutica efectiva para aumentar el ritmo de aprendizaje y el grado deretencion memoristica en animales. Expired ES336642A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US526345A US3348999A (en) 1966-02-10 1966-02-10 Compositions to enhance the learning rate and retention level in animals comprising 2-imino-5-phenyl-4-oxazolidinone and a relatively insoluble base

Publications (1)

Publication Number Publication Date
ES336642A1 true ES336642A1 (es) 1968-01-01

Family

ID=24096955

Family Applications (1)

Application Number Title Priority Date Filing Date
ES336642A Expired ES336642A1 (es) 1966-02-10 1967-02-09 Un metodo de preparacion de una composicion farmaceutica efectiva para aumentar el ritmo de aprendizaje y el grado deretencion memoristica en animales.

Country Status (10)

Country Link
US (1) US3348999A (US20100056889A1-20100304-C00004.png)
BE (1) BE693829A (US20100056889A1-20100304-C00004.png)
CH (1) CH519847A (US20100056889A1-20100304-C00004.png)
DE (1) DE1617287A1 (US20100056889A1-20100304-C00004.png)
ES (1) ES336642A1 (US20100056889A1-20100304-C00004.png)
FR (1) FR6264M (US20100056889A1-20100304-C00004.png)
GB (1) GB1143061A (US20100056889A1-20100304-C00004.png)
GR (1) GR33338B (US20100056889A1-20100304-C00004.png)
IL (1) IL27353A (US20100056889A1-20100304-C00004.png)
NL (1) NL6701761A (US20100056889A1-20100304-C00004.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689644A (en) * 1971-01-27 1972-09-05 Abbott Lab 2-imino-5-phenyl-4-oxazolidinone and a potentiating agent to treat parkinson{40 s disease
US3689643A (en) * 1971-01-27 1972-09-05 Abbott Lab Combination of l-dopa, 2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinson{40 s disease
US4754047A (en) * 1979-08-16 1988-06-28 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and/or improving the efficiency of feed utilization thereby
US4522822A (en) * 1980-12-22 1985-06-11 American Cyanamid Company Phenylethane derivatives and acid addition salts thereof for increasing lean meat deposition and/or improving lean meat to fat ratio in warm blooded animals
US4501751A (en) * 1980-12-22 1985-02-26 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby

Also Published As

Publication number Publication date
FR6264M (US20100056889A1-20100304-C00004.png) 1968-08-26
BE693829A (US20100056889A1-20100304-C00004.png) 1967-08-09
US3348999A (en) 1967-10-24
GR33338B (el) 1967-11-23
DE1617287A1 (de) 1971-03-25
NL6701761A (US20100056889A1-20100304-C00004.png) 1967-08-11
CH519847A (de) 1972-03-15
IL27353A (en) 1970-12-24
GB1143061A (en) 1969-02-19

Similar Documents

Publication Publication Date Title
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ES403435A1 (es) Metodo para la preparacion de una composicion farmaceutica de liberacion lenta.
LV11103A (lv) Perorali lietojama zalu forma centralas nervu sistemas dofamina deficita stavoklu arstesanai
ES412387A1 (es) Procedimiento para la obtencion de formulaciones mejoradas del sabor de penicilinas orales.
SE7407325L (US20100056889A1-20100304-C00004.png)
ES336642A1 (es) Un metodo de preparacion de una composicion farmaceutica efectiva para aumentar el ritmo de aprendizaje y el grado deretencion memoristica en animales.
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
BE827595A (fr) Medicament a administration par voie orale produisant un effet inhibiteur de l'antiplasmine
GB902659A (en) A process for the production of a derivative of thebaine
ES340204A1 (es) Procedimiento para producir compuestos de ferroceno.
ES368325A1 (es) Un procedimiento para la preparacion de un compuesto de ce-falosporina.
ES294897A1 (es) Mejoras introducidas en la preparación de composiciones farmacéuticas en forma de dosis unitarias
DE3064854D1 (en) Quail-egg lyophilisate for the treatment of immuno-allergic diseases
GB1067390A (en) Improvements in or relating to antiviral compositions and treatments
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.
GB1118606A (en) Compositions for the treatment of haemorrhoids
IE32384L (en) Antibiotic veterinary composition
ES348538A1 (es) Procedimiento para la obtencion de nuevas sales de noratro-pina n-sustituida.
GB1339636A (en) Pharmaceutical compositions for inducing skeletal muscle relaxation
ES340846A1 (es) Procedimiento de preparacion del compuesto 3,5,3'-triiodo- tiroacetato de reserpina.
JPS5234914A (en) Method and composition for preventing failing of milk secretion of live stocks
GB976096A (en) Pharmaceutical compositions
FR2036801A1 (en) Coccidiostatic preparation containing antibiotic x-537a or a salt ther - eof
SE334357B (US20100056889A1-20100304-C00004.png)